June 16,2015 – Dermatologists have long known that available treatments for chronic itch, including eczema, are simply not up to scratch. But scientists have now discovered a new gene that promotes itch, suggesting a way forward for powerful new therapies.
June 8, 2015 – I have been a part of the eczema community, and the NEA Board of Directors, for many years I never thought I would see the day when hope and opportunity would converge and we would see a promising future for eczema on the horizon. That day is now!
June 1, 2015 – Patients with either vitiligo, especially early-onset disease, or AA, especially alopecia totalis or alopecia universalis, have significantly increased risk for AD.
May 29, 2015 – Linalyl acetate, a fragrance chemical that is one of the main constituents of the essential oil of lavender, is not on the list of allergenic compounds pursuant to the EU Cosmetics Directive. Thus, it does not need to be declared on cosmetic products sold within the EU. Recent studies at the University of Gothenburg have shown that linalyl acetate can cause allergic eczema.
May 22, 2015 – “Eczema keeps me from doing things that other people enjoy all the time, like going to the beach, riding my bike, going for a walk, and enjoying being outside,” says 13-year-old eczema patient, Isaiah Dixon. But that didn’t stop Isaiah from testifying in March at a Food and Drug Administration (FDA) hearing in Silver Spring, MD, on behalf of the National Eczema Association.
May 7, 2015 – Researchers from St. Jude Children’s Research Hospital have identified a protein that offers a new focus for developing targeted therapies to tame severe inflammation. Targeting this protein has lead to a greater understanding on how mutations in a protein can lead to atopic dermatitis.
May 7, 2015 – Patients with atopic dermatitis had a slightly increased risk of lymphoma, with the severity of atopic dermatitis a potentially significant risk factor, according to recently published study results.
April 9, 2015 – Children with common allergic diseases such as atopic dermatitis and allergic rhinitis showed a greater risk for developing primary immune thrombocytopenia, according to study results.
March 31, 2015 – A ninth-century remedy for eye infections has been found to kill the modern-day superbug MRSA and disrupt naturally antibiotic-resistant biofilms in tests conducted by researchers.
March 10, 2015 – On March 9, 2015, NEA CEO Julie Block, 13-year old eczema patient Isaiah, 17-year old eczema patient Gracie, and their parents were present at an important Food and Drug Administrative (FDA) hearing regarding the unmet medical need for atopic dermatitis therapies in pediatrics.